Skip to content

Effect of Nigella sativa on acne vulgaris

Formulation and standardization of topical product of Nigella sativa L. and study on its effects in acne vulgaris, a randomized double-blind clinical study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180712040449N1
Enrollment
56
Registered
2018-09-25
Start date
2018-10-21
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group: 28 patients receive semi-solid preparations of Nigella sativa, twice daily for 60 days. Intervention 2: Control group: 28 patients receive semi-solid preparations o

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients between 14–35 years old from both genders Patients with mild to moderate acne as defined by the Investigator’s Global Assessment (IGA) scale Enrolled female participants should have a negative pregnancy test

Exclusion criteria

Exclusion criteria: Any aesthetic facial procedure including laser therapy and tissue/dermal injectables within the last 6 months Patients having wound and infection on face Patients with any skin disorders that might interfere with the diagnosis or evaluation of acne Very severe acne vulgaris Pregnancy or breastfeeding Patients with any uncontrolled systemic disease Using oral isotretinoin in the last 6 months History of hypersensitivity to blackseed

Design outcomes

Primary

MeasureTime frame
People with mild to moderate acne vulgaris. Timepoint: Acne lesions counting at baseline, days 14, 30, and 60. Method of measurement: Investigator’s global assessment grading for acne vulgaris.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Soleymani

Tehran University of Medical Sciences

s.soleymani84@gmail.com+98 21 8899 3656

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026